Lifecycle Regulation of Artificial Intelligence– and Machine Learning–Based Software in Medicine

This Viewpoint discusses the appropriateness of existing US Food and Drug Administration regulatory pathways for artificial intelligence (AI) and machine learning (ML) software in health care, and proposes a lifecyle-based framework given the iterative nature of AI/ML algorithms, including…

Read the full article here

Related Articles